Teijin Pharma Of Japan Expands Home Healthcare Business Overseas
This article was originally published in PharmAsia News
Tokyo-based Teijin Pharma has accelerated expansion of its home medical care business in the U.S., Europe and Korea. In January, the company acquired Buffalo, New York-based Associated Healthcare Systems, and started providing medical devices to treat adult sleep apnea syndrome. In Europe, Teijin plans to enter the oxygen concentrators and sleep apnea syndrome therapy markets and it aims to establish a joint venture with a European pharmaceutical company this summer. In Korea, Teijin established a joint venture that offers oxygen concentrators rental service with a local pharmaceutical company. (Click here for more - Japanese language) "Teijin Pharma Speeds Up Expansion of Home Healthcare To Overseas" - Nikkan Kogyo News (4/23/08)
You may also be interested in...
Deputy CEO Nicolas Hieronimus will take L’Oreal’s helm beginning in May 2021, with Jean-Paul Agon continuing as chairman, the firm announced on 14 October. The Estee Lauder Companies hires PepsiCo’s Gibu Thomas to lead its online business, and Coty appoints its first chief digital officer.
US FDA looks to post-marketing studies to address elements of the NDA that were not central to its initial swift approval as the first COVID-19 therapy, including pediatric use and the interaction of hepatotoxicity and dose duration.
But advisory committee members caution against including pediatric population in COVID-19 vaccine trials, and one member expresses concern that Pfizer is testing those as young as 12 years of age. Agency is in discussions with product sponsors about enrollment of adolescents.